Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AMDANASDAQ:CVRXNASDAQ:KRMDNASDAQ:PDEX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMDAAmedica$3.16-5.4%$0.26$0.18▼$6.40$37.51M-1.241.07 million shs65,288 shsCVRXCVRx$6.34+2.4%$8.68$4.30▼$18.55$165.30M1.39332,681 shs501,346 shsKRMDKORU Medical Systems$2.95-3.6%$2.64$1.86▼$5.05$136.12M0.39139,515 shs82,930 shsPDEXPro-Dex$43.12$53.36$16.84▼$70.26$140.61M0.3729,693 shs36,519 shs2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMDAAmedica-5.39%+22.01%+82.66%+7.12%+5,645.45%CVRXCVRx0.00%+34.89%+1.44%-57.99%-21.34%KRMDKORU Medical Systems0.00%-6.35%+29.96%-32.49%+31.11%PDEXPro-Dex0.00%-2.64%-29.11%+21.74%+120.11%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAMDAAmedicaN/AN/AN/AN/AN/AN/AN/AN/ACVRXCVRx2.8928 of 5 stars3.42.00.00.02.74.20.6KRMDKORU Medical Systems2.8869 of 5 stars3.53.00.00.02.92.50.6PDEXPro-Dex2.6369 of 5 stars2.52.00.00.03.42.51.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAMDAAmedica 0.00N/AN/AN/ACVRXCVRx 2.71Moderate Buy$14.50128.71% UpsideKRMDKORU Medical Systems 3.00Buy$4.5052.54% UpsidePDEXPro-Dex 3.00Buy$52.0020.59% UpsideCurrent Analyst Ratings BreakdownLatest AMDA, PDEX, KRMD, and CVRX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/9/2025CVRXCVRxPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$20.00 ➝ $12.005/9/2025CVRXCVRxJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Underweight$15.00 ➝ $7.005/8/2025KRMDKORU Medical SystemsPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$4.50 ➝ $3.504/8/2025CVRXCVRxLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$19.00 ➝ $14.004/8/2025CVRXCVRxCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$23.00 ➝ $18.003/13/2025KRMDKORU Medical SystemsB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy(Data available from 5/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAMDAAmedica$11.23M3.34N/AN/A$1.80 per share1.76CVRXCVRx$52.87M3.13N/AN/A$2.73 per share2.32KRMDKORU Medical Systems$35.08M3.88N/AN/A$0.45 per share6.56PDEXPro-Dex$64.12M2.19$1.24 per share34.81$9.76 per share4.42Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAMDAAmedica-$9.32M-$3.13N/AN/AN/A-139.62%-148.60%-67.83%N/ACVRXCVRx-$59.97M-$2.18N/AN/AN/A-116.91%-93.06%-51.78%8/4/2025 (Estimated)KRMDKORU Medical Systems-$13.74M-$0.11N/AN/AN/A-37.42%-24.60%-16.87%N/APDEXPro-Dex$2.13M$2.8021.4520.93N/A11.06%21.68%12.40%N/ALatest AMDA, PDEX, KRMD, and CVRX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025CVRXCVRx-$0.56-$0.53+$0.03-$0.53$14.68 million$12.35 million5/7/2025Q1 2025KRMDKORU Medical Systems-$0.02-$0.03-$0.01-$0.03$8.86 million$9.64 million5/1/2025Q3 2025PDEXPro-Dex$0.47$0.98+$0.51$0.98$17.70 million$17.41 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAMDAAmedicaN/AN/AN/AN/AN/ACVRXCVRxN/AN/AN/AN/AN/AKRMDKORU Medical SystemsN/AN/AN/AN/AN/APDEXPro-DexN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAMDAAmedicaN/A1.110.99CVRXCVRx0.6912.0610.23KRMDKORU Medical Systems0.012.992.37PDEXPro-Dex0.332.581.44Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAMDAAmedica3.72%CVRXCVRx75.27%KRMDKORU Medical Systems58.60%PDEXPro-Dex15.28%Insider OwnershipCompanyInsider OwnershipAMDAAmedica0.90%CVRXCVRx13.90%KRMDKORU Medical Systems20.60%PDEXPro-Dex47.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAMDAAmedicaN/A11.87 millionN/ANot OptionableCVRXCVRx16026.07 million21.12 millionOptionableKRMDKORU Medical Systems8046.14 million34.10 millionOptionablePDEXPro-Dex1403.26 million1.71 millionNot OptionableAMDA, PDEX, KRMD, and CVRX HeadlinesRecent News About These CompaniesPro-Dex (NASDAQ:PDEX) Share Price Crosses Below Two Hundred Day Moving Average - Should You Sell?May 15 at 3:49 AM | marketbeat.com9,260 Shares in Pro-Dex, Inc. (NASDAQ:PDEX) Bought by Marshall Wace LLPMay 6, 2025 | marketbeat.comPro-Dex: Crash After Strong Earnings Leads To A Buying OpportunityMay 5, 2025 | seekingalpha.comHere's Why Pro-Dex (NASDAQ:PDEX) Has Caught The Eye Of InvestorsMay 4, 2025 | uk.finance.yahoo.com683 Capital Management LLC Makes New $739,000 Investment in Pro-Dex, Inc. (NASDAQ:PDEX)May 4, 2025 | marketbeat.comShort Interest in Pro-Dex, Inc. (NASDAQ:PDEX) Rises By 61.9%May 2, 2025 | marketbeat.comPro-Dex, Inc. (PDEX) Q3 Earnings Surpass EstimatesMay 1, 2025 | zacks.comPro-Dex, Inc. Announces Fiscal 2025 Third Quarter and Nine-Month ResultsMay 1, 2025 | accessnewswire.comRussell Investments Group Ltd. Buys Shares of 6,999 Pro-Dex, Inc. (NASDAQ:PDEX)April 27, 2025 | marketbeat.comPro-Dex (PDEX) Expected to Announce Earnings on ThursdayApril 26, 2025 | marketbeat.comProDex (PDEX) Moves 5.1% Higher: Will This Strength Last?April 25, 2025 | zacks.comTake the Zacks Approach to Beat the Markets: Pro-Dex, Brookdale Senior Living, Coca-Cola in FocusApril 21, 2025 | zacks.comPro-Dex, Inc. (NASDAQ:PDEX) Sees Significant Increase in Short InterestApril 20, 2025 | marketbeat.comEAM Investors LLC Buys New Stake in Pro-Dex, Inc. (NASDAQ:PDEX)April 19, 2025 | marketbeat.comProDex (PDEX) Surges 7.4%: Is This an Indication of Further Gains?April 3, 2025 | zacks.comPro-Dex, Inc. (NASDAQ:PDEX) Director Raymond E. Cabillot Sells 842 SharesApril 2, 2025 | insidertrades.comPro-Dex, Inc. (NASDAQ:PDEX) Director Raymond E. Cabillot Sells 836 SharesApril 1, 2025 | insidertrades.comInsider Selling: Pro-Dex, Inc. (NASDAQ:PDEX) Director Sells 3,096 Shares of StockMarch 28, 2025 | insidertrades.comInsider Selling: Pro-Dex, Inc. (NASDAQ:PDEX) Director Sells 5,151 Shares of StockMarch 18, 2025 | insidertrades.comWith 38% ownership in Pro-Dex, Inc. (NASDAQ:PDEX), hedge funds investors have a lot riding on the businessMarch 11, 2025 | finance.yahoo.comProDex (PDEX) Upgraded to Strong Buy: Here's What You Should KnowFebruary 28, 2025 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeAMDA, PDEX, KRMD, and CVRX Company DescriptionsAmedica NASDAQ:AMDASINTX Technologies, Inc. engages in the development and commercialization of silicon nitride for medical and non-medical applications. It markets spinal fusion products and develops products for use in total hip and knee joint replacements. The company was founded by Aaron A. Hofmann and Ashok C. Khandkar in 1996 and is headquartered in Salt Lake City, UT.CVRx NASDAQ:CVRX$6.34 +0.15 (+2.42%) Closing price 05/16/2025 04:00 PM EasternExtended Trading$6.50 +0.16 (+2.52%) As of 05/16/2025 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.KORU Medical Systems NASDAQ:KRMD$2.95 -0.11 (-3.59%) Closing price 05/16/2025 04:00 PM EasternExtended Trading$2.94 -0.01 (-0.17%) As of 05/16/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.Pro-Dex NASDAQ:PDEX$43.12 0.00 (0.00%) Closing price 05/16/2025 04:00 PM EasternExtended Trading$43.04 -0.07 (-0.17%) As of 05/16/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/12 - 05/16 Retail Investors Are Betting Big on Rocket Lab—Should You Too? Meta's 5 Key Pillars for AI Growth—Zuckerberg's Bold Vision Taiwan Semiconductor Stock Is The Gift That Keeps on Giving GE Aerospace: Qatar Deal Fuels Multi-Billion Dollar Growth Engine Alibaba's Earnings Just Changed Everything for the Stock Plug Power: Is Q1 Noise An Opportunity for Accumulation? Cisco Stock Eyes New Highs in 2025 on AI, Earnings, Upgrades Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
